Inventurus Knowledge Solutions: IKS Health Launches Audit-Ready Autonomous Coding With Expert Human Support, Claiming Up To 95% Accuracy

2 min read     Updated on 08 Apr 2026, 05:27 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Inventurus Knowledge Solutions, operating as IKS Health, has launched an advanced AI-driven autonomous coding engine that delivers up to 95% coding accuracy while addressing the 12% average claim denial rate in U.S. healthcare. The solution integrates with Epic Connection Hub and combines artificial intelligence with expert human review processes to analyze patient charts and suggest medical codes. The system provides comprehensive audit readiness with justification reports and operates as a vendor-agnostic solution compatible with various healthcare systems.

powered bylight_fuzz_icon
37151464

*this image is generated using AI for illustrative purposes only.

Inventurus Knowledge Solutions Limited, operating as IKS Health, has announced the launch of its AI-driven revenue cycle management audit-ready coding engine designed to enhance coding accuracy and reduce claim denials in healthcare operations.

Advanced AI-Driven Coding Technology

The newly launched autonomous coding engine delivers up to 95% coding accuracy while addressing the significant challenge of claim denials in the U.S. healthcare system, where the average denial rate stands at 12%. The solution is now integrated with Epic and available in the Epic Connection Hub, combining artificial intelligence-driven code assignment with expert human review processes.

Key Performance Metrics: Details
Coding Accuracy: Up to 95%
Audit Trail Coverage: 100% on every claim
Automated Chart Processing: More than 80%
Average U.S. Claim Denial Rate: 12%

Comprehensive Coding Workflow

The autonomous coding engine utilizes structured and coding-ready clinical documentation to analyze patient charts through AI and rule-based logic. The system suggests CPT, ICD, and E/M codes while providing confidence scores for every code generated. Human coders review low-confidence codes, while AI-approved codes flow through rules and payer validation processes.

The accuracy framework includes multiple validation layers:

  • Pre-bill review layer
  • Revenue rules check
  • Compliance validation
  • Payor propensity analysis

According to Mayank Pant, Executive Vice President of Product Management, the solution allows clinicians to focus on patient care while maintaining administrative and financial operations flow.

Integration and Compatibility Features

The coding engine operates as a vendor-agnostic solution that integrates with IKS Health's Scribble Now ambient AI scribe solution, creating an agentic AI-powered workflow from chart to code to revenue. The system accepts charts from any source and provides inherent audit readiness with justification reports citing specific charted clinical evidence.

Solution Features: Capabilities
Integration: Epic Connection Hub
Compatibility: Vendor agnostic
Chart Sources: Any source accepted
Documentation: Justification reports with clinical evidence

Leadership Perspective

Sachin K. Gupta, Founder and Global CEO of IKS Health, emphasized that the autonomous coding workflow represents a key component of the company's full RCM platform. The solution aims to remove unnecessary burdens from clinicians while strengthening administrative and financial aspects of healthcare organizations.

Company Background

IKS Health operates as a global leader in care enablement solutions across the patient journey, focusing on reducing administrative, clinical, and operational burdens in healthcare. The company was founded in 2006 and has received recognition from Black Book as the top provider of AI-driven RCM services, KLAS for performance and client satisfaction, and Google Cloud with a DORA Award for "Augmenting Human Expertise with AI."

Historical Stock Returns for Inventurus Knowledge Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+4.22%+14.65%+17.97%+0.79%+15.50%-21.48%

How will competing healthcare technology companies respond to IKS Health's 95% coding accuracy claims, and what innovations might emerge in the RCM space?

What regulatory challenges could arise as AI-driven coding becomes more prevalent in healthcare billing and compliance?

Will IKS Health's success with Epic integration lead to similar partnerships with other major EHR providers like Cerner or Allscripts?

Inventurus Knowledge Solutions
View Company Insights
View All News
like18
dislike

Inventurus Knowledge Solutions Completes USD 40M Investment in Subsidiary IKS Inc

1 min read     Updated on 02 Apr 2026, 12:09 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Inventurus Knowledge Solutions has successfully completed its comprehensive investment plan in wholly owned subsidiary IKS Inc, investing approximately USD 40 million across two tranches. The company acquired a total of 62,176 shares, with the final tranche of USD 20,990,505 for 32,635 shares completed in April 2026, demonstrating strategic commitment to strengthening subsidiary operations.

powered bylight_fuzz_icon
36208906

*this image is generated using AI for illustrative purposes only.

Inventurus Knowledge Solutions Limited has successfully completed its comprehensive investment plan in wholly owned subsidiary IKS Inc, with the latest regulatory filing dated April 2, 2026, confirming the conclusion of the second and final tranche. The company has now invested a total of approximately USD 40 million across both investment phases.

Investment Completion Details

The company announced the completion of its second tranche investment in Inventurus Knowledge Solutions, Inc. (IKS Inc.), marking the conclusion of the investment plan initially approved by the Board on March 13, 2026.

Investment Phase: Shares Acquired Investment Amount Date Completed
First Tranche: 29,541 shares USD 19,000,476 March 27, 2026
Second Tranche: 32,635 shares USD 20,990,505 April 2, 2026
Total Investment: 62,176 shares USD 39,990,981 Completed

Regulatory Compliance Framework

The investment follows a structured regulatory disclosure process under SEBI LODR Regulations. The company maintained transparency through multiple filings, starting with the Board approval disclosure on March 13, 2026, followed by the first tranche completion on March 27, 2026, and concluding with the final tranche completion on April 2, 2026.

All disclosures were made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with both BSE and NSE being formally notified at each stage of the investment process.

Strategic Investment Significance

This substantial USD 40 million investment represents Inventurus Knowledge Solutions' significant commitment to strengthening its US-based subsidiary operations. The acquisition of over 62,000 shares demonstrates the company's strategic focus on expanding its subsidiary's capabilities and market presence.

The completion of this two-phase investment plan positions IKS Inc. for enhanced operational capacity and growth potential within the Inventurus Knowledge Solutions ecosystem. Company Secretary and Compliance Officer Sameer Chavan executed both tranches, ensuring proper documentation and regulatory compliance throughout the entire investment process.

Historical Stock Returns for Inventurus Knowledge Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+4.22%+14.65%+17.97%+0.79%+15.50%-21.48%

What specific growth initiatives or market expansion plans will IKS Inc. pursue with this $40 million capital infusion?

How might this substantial investment in the US subsidiary affect Inventurus Knowledge Solutions' overall revenue distribution between domestic and international markets?

Will this investment trigger any changes in IKS Inc.'s operational structure or lead to potential acquisitions in the US market?

Inventurus Knowledge Solutions
View Company Insights
View All News
like18
dislike

More News on Inventurus Knowledge Solutions

1 Year Returns:+15.50%